Chimeric Antigen Receptor (CAR)-Specific Monoclonal Antibody to Detect CD19-Specific T Cells in Clinical Trials

por Jena, Bipulendu, Maiti, Sourindra, Huls, Helen, Singh, Harjeet, Lee, Dean A., Champlin, Richard E., Cooper, Laurence J. N.
Publicado 2013

Bioengineering cytotoxic T cells to target opportunistic fungal infection

por Kumaresan, Pappanaicken, Manuri, Pallavi R, Albert, Nathaniel, Rabinovich, Brian, Olivares, Simon, Maiti, Sourindra N, Huls, Helen, Lee, Dean A, Kontoyiannis, Dimitrios, Cooper, Laurence J
Publicado 2013

Tumor Lysing Genetically Engineered T Cells Loaded with Multi-Modal Imaging Agents

por Bhatnagar, Parijat, Alauddin, Mian, Bankson, James A., Kirui, Dickson, Seifi, Payam, Huls, Helen, Lee, Dean A., Babakhani, Aydin, Ferrari, Mauro, Li, King C., Cooper, Laurence J. N.
Publicado 2014

Genetically modified artificial antigen-presenting cells (aAPC) for expansion of melanoma tumor infiltrating lymphocytes with optimal properties for adoptive cell therapy

por Forget, Marie-Andrée, Malu, Shruti, Liu, Hiu, Toth, Christopher, Maiti, Sourindra, Kale, Charuta, Bernatchez, Chantale, Huls, Helen, Wang, Ena, Hwu, Patrick, Cooper, Laurence J, Radvanyi, Laszlo G
Publicado 2013

Redirecting Specificity of T cells Using the Sleeping Beauty System to Express Chimeric Antigen Receptors by Mix-and-Matching of V(L) and V(H) Domains Targeting CD123(+) Tumors

por Thokala, Radhika, Olivares, Simon, Mi, Tiejuan, Maiti, Sourindra, Deniger, Drew, Huls, Helen, Torikai, Hiroki, Singh, Harjeet, Champlin, Richard E., Laskowski, Tamara, McNamara, George, Cooper, Laurence J. N.
Publicado 2016

Manufacture of Clinical-Grade CD19-Specific T Cells Stably Expressing Chimeric Antigen Receptor Using Sleeping Beauty System and Artificial Antigen Presenting Cells

por Singh, Harjeet, Figliola, Matthew J., Dawson, Margaret J., Olivares, Simon, Zhang, Ling, Yang, Ge, Maiti, Sourindra, Manuri, Pallavi, Senyukov, Vladimir, Jena, Bipulendu, Kebriaei, Partow, Champlin, Richard E., Huls, Helen, Cooper, Laurence J. N.
Publicado 2013

Adoptive T-cell therapy improves treatment of canine non–Hodgkin lymphoma post chemotherapy

por O'Connor, Colleen M., Sheppard, Sabina, Hartline, Cassie A., Huls, Helen, Johnson, Mark, Palla, Shana L., Maiti, Sourindra, Ma, Wencai, Davis, R. Eric, Craig, Suzanne, Lee, Dean A., Champlin, Richard, Wilson, Heather, Cooper, Laurence J. N.
Publicado 2012

Genetic editing of HLA expression in hematopoietic stem cells to broaden their human application

por Torikai, Hiroki, Mi, Tiejuan, Gragert, Loren, Maiers, Martin, Najjar, Amer, Ang, Sonny, Maiti, Sourindra, Dai, Jianliang, Switzer, Kirsten C., Huls, Helen, Dulay, Gladys P., Reik, Andreas, Rebar, Edward J., Holmes, Michael C., Gregory, Philip D., Champlin, Richard E., Shpall, Elizabeth J., Cooper, Laurence J. N.
Publicado 2016

Sleeping beauty generated CD19 CAR T-Cell therapy for advanced B-Cell hematological malignancies

por Singh, Harjeet, Srour, Samer A., Milton, Denái R., McCarty, Jessica, Dai, Cuiping, Gaballa, Mahmoud R., Ammari, Mariam, Olivares, Simon, Huls, Helen, De Groot, Eleanor, Marin, David, Petropoulos, Demetrios, Olson, Amanda L., Anderlini, Paolo, Im, Jin S., Khouri, Issa, Hosing, Chitra M., Rezvani, Katayoun, Champlin, Richard E., Shpall, Elizabeth J., Cooper, Laurence J. N., Kebriaei, Partow
Publicado 2022